Alnara

Acquired

Alnara is a biotech company in Cambridge, United States, founded in 2008. It has raised $55.0M across 2 rounds, most recently a $35.0M Series B in 2009 (est.).

Employees
11–50
Founded
2008
Business Model
B2B
Website
alnara.com
Total Funding
$55.0M
Last Round
$35.0M Series BJan 2009
Rounds
2
Acquisition Date
Jul 2010

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Alnara Pharmaceuticals, Inc. was a Cambridge, Massachusetts-based biotechnology company dedicated to developing and commercializing novel protein therapeutics for the treatment of metabolic diseases. Co-founded in 2008 by Alexey Margolin, Rich Aldrich, and Christoph Westphal, Alnara's innovative approach focused on designing effective protein therapies that could be orally delivered directly to the gastrointestinal tract without systemic absorption. The company's lead product, liprotamase, was a non-porcine pancreatic enzyme replacement therapy (PERT) for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis and chronic pancreatitis, which completed Phase 3 clinical trials. Alnara was backed by Third Rock Ventures, Frazier Healthcare, MPM Capital, Bessemer Venture Partners, and Longwood Founders Fund, and was acquired by Eli Lilly and Company in 2010.

Summary

It lists 11–50 employees. It has raised $55.0M in total across 2 rounds, most recently a $35.0M Series B round in 2009 (est.). Investors include Eli Lilly, Bessemer Venture Partners and Third Rock Ventures.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionJul 2010

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alnara on Indexed.vc
<a href="https://indexed.vc/companies/alnara"><img src="https://indexed.vc/api/badge/company/alnara" alt="Alnara on Indexed.vc" width="260" height="76" /></a>